CAS: 1629615-23-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Suptavumab REF: TM-T76992CAS: 1629615-23-1 | SDS-PAGE:96.3%;SEC-HPLC:99.2% | 305.00 €~3,464.00 € | Wed 04 Dec 24 |
 | Suptavumab REF: 3D-CLA1435CAS: 1629615-23-1 | - - - | To inquire | Mon 16 Dec 24 |
Suptavumab
CAS:1629615-23-1
Suptavumab (REGN2222) is a human antibody targeting subtypes A & B of RSV for research.
Purity:
SDS-PAGE:96.3%;SEC-HPLC:99.2%
Color and Shape:
Liquid
Molecular weight:
146.04 kDa
Ref: TM-T76992
| 1mg | 305.00 € | ||
| 5mg | 802.00 € | ||
| 10mg | 1,282.00 € | ||
| 25mg | 1,839.00 € | ||
| 50mg | 2,573.00 € | ||
| 100mg | 3,464.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Suptavumab
CAS:1629615-23-1
Humanized monoclonal antibody targeting the respiratory syncytial virus fusion protein
Ref: 3D-CLA1435
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
